Sulsal Haque1, Vidhya Karivedu1, Muhammed K Riaz1, David Choi2, Logan Roof1, Sarah Z Hassan1, Zheng Zhu3, Roman Jandarov3, Vinita Takiar4, Alice Tang2, Trisha Wise-Draper5. 1. Department of Internal Medicine, Division of Hematology/Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA. 2. Department of Otolaryngology, University of Cincinnati College of Medicine, Cincinnati, OH, USA. 3. Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH, USA. 4. Department of Radiation Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA. 5. Department of Internal Medicine, Division of Hematology/Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Electronic address: wiseth@ucmail.uc.edu.
Abstract
OBJECTIVES: Salvage surgical resection is the preferred treatment for head and neck squamous cell carcinoma (HNSCC) patients who develop locally recurrent disease after failing primary therapy. However, salvage surgical resection is not always feasible, and survival outcomes for those that do undergo salvage remain poor. It is well known that patients with adverse pathological features (extracapsular extension (ECE) of lymph nodes (LN), positive margins, perineural invasion (PNI), lymphovascular invasion (LVI), and multiple LN metastases) at the time of primary surgical resection are likely to have relatively poor outcomes. However, the impact of adverse pathological features on outcomes in the salvage setting remains controversial. MATERIALS AND METHODS: We retrospectively analyzed 73 patients at a single institution from 2008 to 2017 who developed recurrence and subsequently underwent salvage surgery (SS) after definitive curative-intent therapy including radiation. Demographic and disease control outcomes were reviewed. Kaplan-Meier curves were used to estimate relapse free survival (RFS) and overall survival (OS). RESULTS: Median age at diagnosis was 61 years (range 40-86), 49/73 (67%) were male, and 55/73 (75%) had smoked. Patients with any adverse pathological features at SS had worse RFS (HR 3.15 p = 0.0008) and worse OS (3.97 p = 0.0008). Patients who relapsed <6 months after initial therapy had worse OS (HR 2.96 p = 0.004). CONCLUSIONS: Patients with adverse pathological features at time of salvage surgery as well as those who have an early recurrence after definitive treatment and salvage surgery have worse outcomes. Prospective studies are necessary to clarify which patients should receive more intense treatment at salvage.
OBJECTIVES: Salvage surgical resection is the preferred treatment for head and neck squamous cell carcinoma (HNSCC) patients who develop locally recurrent disease after failing primary therapy. However, salvage surgical resection is not always feasible, and survival outcomes for those that do undergo salvage remain poor. It is well known that patients with adverse pathological features (extracapsular extension (ECE) of lymph nodes (LN), positive margins, perineural invasion (PNI), lymphovascular invasion (LVI), and multiple LN metastases) at the time of primary surgical resection are likely to have relatively poor outcomes. However, the impact of adverse pathological features on outcomes in the salvage setting remains controversial. MATERIALS AND METHODS: We retrospectively analyzed 73 patients at a single institution from 2008 to 2017 who developed recurrence and subsequently underwent salvage surgery (SS) after definitive curative-intent therapy including radiation. Demographic and disease control outcomes were reviewed. Kaplan-Meier curves were used to estimate relapse free survival (RFS) and overall survival (OS). RESULTS: Median age at diagnosis was 61 years (range 40-86), 49/73 (67%) were male, and 55/73 (75%) had smoked. Patients with any adverse pathological features at SS had worse RFS (HR 3.15 p = 0.0008) and worse OS (3.97 p = 0.0008). Patients who relapsed <6 months after initial therapy had worse OS (HR 2.96 p = 0.004). CONCLUSIONS:Patients with adverse pathological features at time of salvage surgery as well as those who have an early recurrence after definitive treatment and salvage surgery have worse outcomes. Prospective studies are necessary to clarify which patients should receive more intense treatment at salvage.
Authors: Tanguy Y Seiwert; Barbara Burtness; Ranee Mehra; Jared Weiss; Raanan Berger; Joseph Paul Eder; Karl Heath; Terrill McClanahan; Jared Lunceford; Christine Gause; Jonathan D Cheng; Laura Q Chow Journal: Lancet Oncol Date: 2016-05-27 Impact factor: 41.316
Authors: Jack Phan; Terence T Sio; Theresa P Nguyen; Vinita Takiar; G Brandon Gunn; Adam S Garden; David I Rosenthal; Clifton D Fuller; William H Morrison; Beth Beadle; Dominic Ma; Mark E Zafereo; Kate A Hutcheson; Michael E Kupferman; William N William; Steven J Frank Journal: Int J Radiat Oncol Biol Phys Date: 2016-04-13 Impact factor: 7.038
Authors: C-A Righini; K Nadour; C Faure; R Rtail; N Morel; V Beneyton; E Reyt Journal: Eur Ann Otorhinolaryngol Head Neck Dis Date: 2011-11-21 Impact factor: 2.080
Authors: B Brockstein; D J Haraf; A W Rademaker; M S Kies; K M Stenson; F Rosen; B B Mittal; H Pelzer; B B Fung; M-E Witt; B Wenig; L Portugal; R W Weichselbaum; E E Vokes Journal: Ann Oncol Date: 2004-08 Impact factor: 32.976
Authors: JeeHong Kim; Seungwon Kim; William G Albergotti; Phillip A Choi; Daniel James Kaplan; Shira Abberbock; Jonas T Johnson; Neil Gildener-Leapman Journal: JAMA Otolaryngol Head Neck Surg Date: 2015-12 Impact factor: 6.223
Authors: Robert L Ferris; George Blumenschein; Jerome Fayette; Joel Guigay; A Dimitrios Colevas; Lisa Licitra; Kevin Harrington; Stefan Kasper; Everett E Vokes; Caroline Even; Francis Worden; Nabil F Saba; Lara C Iglesias Docampo; Robert Haddad; Tamara Rordorf; Naomi Kiyota; Makoto Tahara; Manish Monga; Mark Lynch; William J Geese; Justin Kopit; James W Shaw; Maura L Gillison Journal: N Engl J Med Date: 2016-10-08 Impact factor: 91.245
Authors: Jennifer L Leddon; Shuchi Gulati; Sulsal Haque; Casey Allen; Sarah Palackdharry; Maria Mathews; Nicky Kurtzweil; Muhammed Kashif Riaz; Vinita Takiar; Misako Nagasaka; Yash Patil; Chad Zender; Alice Tang; Brian Cervenka; Julie McGrath; W Michael Korn; Benjamin H Hinrichs; Roman Jandarov; Nusrat Harun; Ammar Sukari; Trisha M Wise-Draper Journal: Clin Cancer Res Date: 2022-08-15 Impact factor: 13.801
Authors: Shane Mesko; He Wang; Samuel Tung; Congjun Wang; Dario Pasalic; Bhavana V Chapman; Amy C Moreno; Jay P Reddy; Adam S Garden; David I Rosenthal; G Brandon Gunn; Steven J Frank; Clifton D Fuller; William Morrison; Jack Phan Journal: Int J Radiat Oncol Biol Phys Date: 2019-09-30 Impact factor: 7.038